The Heart Failure Society of America annual scientific meeting features the latest in management and late-breaking clinical data related to heart failure.
September 22, 2021
Viet Le, PA-C, details his experience at the Heart Failure Society of America annual meeting from the perspective of a physician assistant.
September 17, 2021
Data from the CONNECT-HF trial from HFSA 2021 suggest use of a digital tool designed to improve adherence could contribute to improving outcomes among patients discharged from the hospital with heart failure with reduced ejection fraction.
September 15, 2021
Presented at HFSA 2021, results of REDWOOD-HCM provide insight into the effects of the oral selective cardiac myosin inhibitor aficamten in patients with obstructive hypertrophic cardiomyopathy.
September 14, 2021
Presented at HFSA 2021, PRESERVED-HF provides evidence suggesting dapagliflozin use was associated with improvements in KCCQ symptom score and 6-minute walking distance in patients with heart failure with preserved ejection fraction.